Jeries Kort, M.D.

Professional Background

A highly skilled hematologist and oncologist with a comprehensive academic and clinical background. Currently serving as an Assistant Professor at the University of Kansas Medical Center, specializing in Plasma Cell Disorders. Earned an MD from Al-Quds University in Jerusalem, followed by rigorous international training at the American University of Beirut. Completed residency training in Internal Medicine, followed by a fellowship in Hematology and Oncology, including a Chief Fellowship at Case Western Reserve University and University Hospitals. Recipient of prestigious awards, including the SOHO Young Investigator Award and the Harold C. Klein Humanism Award, demonstrating a strong commitment to advancing cancer therapies and improving patient outcomes. Contributed extensively to peer-reviewed literature and regularly presented at international scientific conferences, promoting interdisciplinary collaboration and ongoing advancements in the field.

• MD, MD, Al-Quds University- Jerusalem, Palestine
• Internship, Internal Medicine, Palestine Medical Complex- Ramallah, Palestine
• Residency, Internal Medicine, Al-Makassed Hospital- Jerusalem, Palestine
• Residency, Internal Medicine, American University of Beirut Medical Center- Beirut, Lebanon
• Residency, Internal Medicine, University Hospitals/Case Western Reserve University- Cleveland, Ohio
• Clinical Fellowship, Hematology-Oncology, Case Western Reserve University- Cleveland, Ohio
• Clinical Fellowship, Hematology-Oncology, Case Western Reserve University- Cleveland, Ohio

• American Board of Internal Medicine- Internal Medicine, American Board of Internal Medicine
• Kansas State License, Kansas State Board of Healing Arts

• International Myeloma Society , Member, 2022 - 2026
• American Society for Transplantation and Cellular Therapy , Member, 2019 - 2026
• American Society of Clinical Oncology , Member, 2019 - 2026
• American Society of Hematology , Member, 2019 - 2026
• European Society of Blood and Marrow Transplantation , Member, 2018 - 2023
• Society of Hematologic Oncology , Member, 2018 - 2026

---

• Koubar SH, Kort J, Kawtharani S, Chaaya M, Makki M, Uthman I. 2019. Characteristics of lupus and lupus nephritis at a tertiary care center in Lebanon. Lupus, 28 (13), 1598-1603. https://doi.org/10.1177/0961203319877459
• El Sayed Rola, El Jamal Lara, El Iskandarani Sarah, Kort Jeries, Abdel Salam Mahmoud, Assi Hazem. 2019. Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical Trials. Frontiers in Oncology, 9. https://doi.org/10.3389/fonc.2019.00510
• Kort Jeries, Chidiac Amanda, El Sayed Rola, Massoud Radwan, Nehme Rita, Bazarbachi Ali, El-Cheikh Jean. 2020. Safety and efficacy of four cycles of Brentuximab Vedotin as consolidation after autologous peripheral stem cell transplantation in relapsed/refractory Hodgkin lymphoma. Leukemia & Lymphoma, 61 (7), 1732-1735. https://doi.org/10.1080/10428194.2020.1728755
• El Sayed Rola, El Darsa Haidar, Kort Jeries, Al Chami Farouk, Ibrahim Ali, Charafeddine Maya, Bazarbachi Ali, Abou Dalle Iman, El Cheikh Jean. 2021. Safety and Efficacy of Replacing Vindesine with Vincristine in R-ACVBP Regimen for the Treatment of Large B Cell Lymphomas. Clinical Lymphoma Myeloma and Leukemia, 21 (10), 711-719. https://doi.org/10.1016/j.clml.2021.05.011
• Rana PS, Murphy EV, Kort J, Driscoll JJ. 2022. Road testing new CAR design strategies in multiple myeloma.. Frontiers in immunology, 13, 957157
• Malek Ehsan, Kort Jeries, Metheny Leland, Fu Pingfu, Li Gen, Hari Parameswaran, Efebera Yvonne, Callander Natalie S, Qazilbash Muzaffar H, Giralt Sergio, Krishnan Amrita, Stadtmauer Edward A, Lazarus Hillard M. 2024. Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial. Transplantation and Cellular Therapy, 30 (7), 698.e1-698.e10. https://doi.org/10.1016/j.jtct.2024.01.053
• Doumeth Sarah Abi, Kort Jeries, Pamuk Omer Nuri. 2024. Blood-dominant disease in late-and-early-onset lupus: A systematic review and meta-analysis. Autoimmunity Reviews, 23 (11), 103652. https://doi.org/10.1016/j.autrev.2024.103652
• Kort Jeries, Naleid Nikolas, Oley Frank, Ignatz-Hoover James, Margevicius Seunghee, Fu Pingfu, Malek Ehsan, Cooper Brenda. 2025. Melphalan 140 mg/m2 is Safe and Effective for Frail and Older Multiple Myeloma Patients With Comparable Rates of Minimal Residual Disease Negativity. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2025.02.004